Skip to main content
SpringerLink
Log in

Drug discrimination studies with MDMA and amphetamine

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The term entactogen has recently been introduced to describe a new pharmacological class of compounds best represented by 3,4-methylenedioxymethamphetamine, MDMA, and its alpha-ethyl homologue MBDB. The present study was designed to test the similarities of the discriminative stimulus properties produced by MDMA and MBDB, as well as to elaborate further the distinction between entactogens, hallucinogens and stimulants. Two groups of rats were trained to discriminate saline from either racemic MDMA hydrochloride (1.75 mg/kg) or S-(+)-amphetamine sulfate (1.0 mg/kg) in a two-lever drug discrimination task. The (±)-MDMA cue completely generalized to S-(+)-MDMA, S-(+)-amphetamine, (±)-MDA, S-(+)-MBDB, (±)-MBDB, R-(-)-MDMA, and R-(-)-MBDB, but not to LSD or DOM. The S-(+)-amphetamine cue generalized to (±)-methamphetamine, but not to racemic MDMA or MBDB, nor to their optical isomers. The S-(+)-isomers of both MDMA and MBDB were more potent than the R-(-)-isomers. The results indicate that MDMA and MBDB may share a component of their discriminative stimulus properties which is different from both stimulants and hallucinogens. Although MDA and MDMA have been shown to be amphetamine-like, the lack of stimulant effects for MBDB suggests that amphetamine-like stimulant activity is not necessary for a compound to share discriminative stimulus properties with MDMA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alles GA (1957) Some relations between chemical structure and physiological action of mescaline and related compounds. In: Abramson HA (ed) Neuropharmacology: transactions, fourth conference. Macy, New York, pp 181–268

    Google Scholar 

  • Anderson GM III, Braun G, Braun U, Nichols DE, Shulgin AT (1978) Absolute configuration and psychotomimetic activity. NIDA Res Monogr 22:8–15

    Google Scholar 

  • Appel JB, Cunningham KA (1986) The use of drug discrimination procedures to characterize hallucinogenic drug actions. Psychopharmacol Bull 22:959–969

    Google Scholar 

  • Barry H III (1974) Classification of drugs according to their discriminable effects in rats. Fed Proc 33:1814–1824

    Google Scholar 

  • Biel JH, Bopp BA (1978) Amphetamines: Structure-activity relationships. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 11. Plenum Press, New York, pp 1–39

    Google Scholar 

  • Boszormenyi SH, Nader MA, Glover KW, Barrett JE (1987) The effects of MDA, MDMA and MDE on schedule-controlled performances in the pigeon. Fed Proc 46:545

    Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenpirone, a LSD-antagonist. J Pharmacol Exp Ther 221:206–214

    Google Scholar 

  • Evans SM, Johanson CE (1986) Discriminative stimulus properties of (±)-3,4-methylenedioxymethamphetamine and (±)-3,4-methylenedioxyamphetamine in pigeons. Drug Alcohol Depend 18:159–164

    Google Scholar 

  • Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology 73:363–371

    Google Scholar 

  • Glennon RA, Young R (1984a) MDA: A psychoactive agent with dual stimulus effects. Life Sci 34:379–383

    Google Scholar 

  • Glennon RA, Young R (1984b) Further investigation of the discriminative stimulus properties of MDA. Pharmacol Biochem Behav 20:501–505

    Google Scholar 

  • Glennon RA, Rosecrans JA, Young R (1981) Behavioral properties of psychoactive phenylisopropylamines in rats. Eur J Pharmacol 76:353–360

    Google Scholar 

  • Glennon RA, Young R, Rosecrans JA, Anderson GM (1982) Discriminative stimulus properties of MDA analogs. Biol Psychiatry 17:807–814

    Google Scholar 

  • Glennon RA, Titeler M, Young R (1986) Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. Psychopharmacol Bull 22:953–958

    Google Scholar 

  • Glennon RA, Little PJ, Rosecrans JA, Yousif M (1987) The effect of MDMA (“Ecstasy”) and its optical isomers on schedule-controlled responding in mice. Pharmacol Biochem Behav 26:425–426

    Google Scholar 

  • Greer G, Tolbert R (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs 18:319–327

    Google Scholar 

  • Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of the enantiomers of MDA, MDMA and related analogues on 3H-serotonin and 3H-dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269–276

    Google Scholar 

  • Kamien JB, Johanson CE, Schuster CR, Woolverton WL (1986) The effects of (±)-methylenedioxymethamphetamine and (±)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. Drug Alcohol Depend 18:139–147

    Google Scholar 

  • Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113

    Google Scholar 

  • Lyon RA, Glennon RA, Titeler M (1986) 3,4-Methylenedioxy-methamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology 88:525–526

    Google Scholar 

  • Martin WR, Vaupel DB, Sloan JW, Bell JA, Nozaki M, Bright LD (1978) The mode of action of LSD-like hallucinogens and their identification. In: Stillman RC, Willette RE (eds) The psychopharmacology of hallucinogens. Pergamon Press, New York, pp 118–125

    Google Scholar 

  • Naranjo C, Shulgin AT, Sargent T (1967) Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Med Pharmacol Exp 17:359–364

    Google Scholar 

  • Nichols DE (1981) Structure-activity relationships of phenethylamine hallucinogens. J Pharm Sci 70:839–849

    Google Scholar 

  • Nichols DE (1986) Differences between the mechanisms of action of MDMA, MBDB, and the classical hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305–313

    Google Scholar 

  • Nichols DE, Lloyd DH, Hoffman AJ, Nichols MB, Yim GKW (1982) Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes. J Med Chem 25:530–535

    Google Scholar 

  • Nichols DE, Hoffman AJ, Oberlender RA, Jacob P III, Shulgin AT (1986) Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. J Med Chem 29:2009–2015

    Google Scholar 

  • Overton DA (1984) State dependent learning and drug discriminations. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 18. Plenum Press, New York, pp 59–126

    Google Scholar 

  • Ricuarte G, Bryan G, Strauss L, Seiden L, Seiden L, Schuster C (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229:986–988

    Google Scholar 

  • Rosecrans JA, Glennon RA (1987) The effect MDA and MDMA (“Ecstasy”) isomers in combination with pirenpirone on operant responding in mice. Pharmacol Biochem Behav 28:39–42

    Google Scholar 

  • Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo effects of methylenedioxymethamphetamine on stiatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747–755

    Google Scholar 

  • Schechter MD (1986) Discriminative profile of MDMA. Pharmacol Biochem Behav 24:1533–1537

    Google Scholar 

  • Schechter MD (1987) MDMA as a discriminative stimulus: isomeric comparisons. Pharmacol Biochem Behav 27:41–44

    Google Scholar 

  • Schechter MD, Rosecrans JA (1973) d-Amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol 21:212–216

    Google Scholar 

  • Shannon HE (1980) MDA and DOM: Substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat. Psychopharmacology 67:311–312

    Google Scholar 

  • Shulgin AT, Nichols DE (1978) Characterization of three new psychotomimetics. In: Stillman RC, Willette RE (eds) The psychopharmacology of hallucinogens. Pergamon Press, New York, pp 74–83

    Google Scholar 

  • Steele TD, Nichols DE, Yim GKW (1987) Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]-monoamines into synaptosomes from different regions of rat brain. Biochem Pharmacol 36:2297–2303

    Google Scholar 

  • Stolerman IP, D'Mello GD (1981) Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology 73:295–303

    Google Scholar 

  • Stone DM, Stahl DC, Hanson GR, Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41–48

    Google Scholar 

  • Turek IS, Soskin RA, Kurland AA (1974) Methylenedioxyamphetamine (MDA) subjective effects. J Psychedelic Drugs 6:7–14

    Google Scholar 

  • White FJ, Appel JB (1981) A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology 73:110–115

    Google Scholar 

  • Wolfson PE (1986) Meetings at the edge with Adam: A man for all seasons? J Psychoactive Drugs 18:329–333

    Google Scholar 

  • Young R, Glennon RA (1986) Discriminative stimulus properties of amphetamine and structurally related phenalkylamines. Med Res Rev 6:99–130

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicinal Chemistry and Pharmacognosy, School of Pharmacy and Pharmacal Sciences, Purdue University, 47907, West Lafayette, IN, USA

    Robert Oberlender & David E. Nichols

Authors
  1. Robert Oberlender
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David E. Nichols
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberlender, R., Nichols, D.E. Drug discrimination studies with MDMA and amphetamine. Psychopharmacology 95, 71–76 (1988). https://doi.org/10.1007/BF00212770

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00212770

Key words

Search

Navigation